Exclusive License, Supply and Distribution Agreement Sample Contracts
Exhibit 10.68 EXCLUSIVE LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT THIS EXCLUSIVE LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT (this "Agreement"), is made as of July 1, 2004, by and between Leiner Health Products, LLC, (a Delaware limited liability...Exclusive License, Supply and Distribution Agreement • November 16th, 2004 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
Standard Contracts
ContractExclusive License, Supply and Distribution Agreement • January 20th, 2021 • Bioventus Inc. • Surgical & medical instruments & apparatus
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
AMENDMENT NO. 1 TO THE EXCLUSIVE LICENSE, SUPPLY AND DISTRIBUTION AGREEMENTExclusive License, Supply and Distribution Agreement • January 20th, 2021 • Bioventus Inc. • Surgical & medical instruments & apparatus
This Amendment No. 1 to the Exclusive License, Supply and Distribution Agreement (the “Amendment”) is entered into on December 31, 2018 (“Effective Date”) by and between Bioventus LLC, a Delaware limited liability company, with its principal place of business at 4721 Emperor Blvd. Suite 100, Durham NC 27703 (“BIOVENTUS”) and IBSA Institut Biochimique SA (Switzerland), a Swiss organization, with a registered office at Via al Ponte 13, 6900 Massagno – Switzerland (“IBSA”). BIOVENTUS and the IBSA each are referred to herein as a “Party” and collectively, as the “Parties”.
AMENDMENT NO. 2 TO THE EXCLUSIVE LICENSE, SUPPLY AND DISTRIBUTION AGREEMENTExclusive License, Supply and Distribution Agreement • February 4th, 2021 • Bioventus Inc. • Surgical & medical instruments & apparatus
This Amendment No. 2 to the Exclusive License, Supply and Distribution Agreement (the “Amendment”) is entered into on December 31, 2020 (“Effective Date”) by and between Bioventus LLC, a Delaware limited liability company, with its principal place of business at 4721 Emperor Blvd. Suite 100, Durham NC 27703 (“BIOVENTUS”) and IBSA Institut Biochimique SA (Switzerland), a Swiss organization, with a registered office at Via al Ponte 13, 6900 Massagno – Switzerland (“IBSA”). BIOVENTUS and the IBSA each are referred to herein as a “Party” and collectively, as the “Parties”.